DAVID POPLACK to Clinical Trials as Topic
This is a "connection" page, showing publications DAVID POPLACK has written about Clinical Trials as Topic.
Connection Strength
0.144
-
Management strategies in acute lymphoblastic leukemia. Oncology (Williston Park). 2011 Apr 15; 25(4):328-35.
Score: 0.067
-
Antiretroviral drug development and clinical pharmacology. Pediatr Infect Dis J. 1991 Nov; 10(11):849-57.
Score: 0.017
-
The child with recurrent solid tumor. Pediatr Clin North Am. 1991 Apr; 38(2):489-504.
Score: 0.017
-
The pharmacokinetics of zidovudine administered by continuous infusion in children. Ann Intern Med. 1989 Feb 15; 110(4):279-85.
Score: 0.014
-
Prophylaxis and treatment of leukemia in the central nervous system and other sanctuaries. Semin Oncol. 1985 Jun; 12(2):131-48.
Score: 0.011
-
Treatment of accidental intrathecal methotrexate overdose with intrathecal carboxypeptidase G2. J Natl Cancer Inst. 2004 Oct 20; 96(20):1557-9.
Score: 0.011
-
Report and recommendations of the Rome workshop concerning poor-prognosis acute lymphoblastic leukemia in children: biologic bases for staging, stratification, and treatment. Med Pediatr Oncol. 1986; 14(3):191-4.
Score: 0.003
-
Duration of empiric antibiotic therapy in granulocytopenic patients with cancer. Am J Med. 1979 Aug; 67(2):194-200.
Score: 0.002
-
Sequential combination chemotherapy (containing high-dose cyclophosphamide) for metastic osteogenic sarcoma. Cancer Treat Rep. 1978 Feb; 62(2):247-50.
Score: 0.002